GRAIL, INC.

Profile

Company Names

GRAIL, INC.

Addresses

1525 O-BRIEN DRIVE, MENLO PARK, CA 94025

Phone Numbers

650-454-6995

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$2,228,060,543.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-10-21 
$324,997,989.00 
$324,997,989.00 
$0.00 
Equity 
3
2019-11-27 
$388,407,514.00 
$425,000,000.00 
$36,592,486.00 
Equity 
2
2018-05-16 
$300,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2017-02-28 
$1,214,655,040.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
HAL 
 
BARRON 
DIRECTOR
JOSE 
 
BASELGA 
DIRECTOR
HANS 
 
BISHOP 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
CHASE 
DIRECTOR
JENNIFER 
 
COOK 
EXECUTIVE OFFICER, DIRECTOR
MIN 
 
CUI 
DIRECTOR
KAYE 
 
FOSTER 
DIRECTOR
KAYE 
 
FOSTER-CHEEK 
DIRECTOR
AARON 
 
FREIDIN 
EXECUTIVE OFFICER
CATHERINE 
 
FRIEDMAN 
DIRECTOR
MAYKIN 
 
HO 
DIRECTOR
JEFFREY 
 
HUBER 
DIRECTOR
JEFFREY 
T. 
HUBER 
EXECUTIVE OFFICER, DIRECTOR
SARAH 
 
KREVANS 
DIRECTOR
STEVE 
 
MIZELL 
DIRECTOR
JOSH 
 
OFMAN 
EXECUTIVE OFFICER
ROBERT 
 
RAGUSA 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
 
RASTETTER 
DIRECTOR, EXECUTIVE OFFICER
GREGORY 
 
SUMME 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2025-10-21 
D/A
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
D
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2018-05-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
GOLDMAN, SACHS + CO.
361
NONE
NONE
ABG, LLC